tiprankstipranks
Larimar Therapeutics, Inc. (LRMR)
:LRMR
US Market

Larimar Therapeutics (LRMR) Income Statement

Compare
577 Followers

Larimar Therapeutics Income Statement

Last quarter (Q3 2024), Larimar Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Larimar Therapeutics's net income was $-15.50M. See Larimar Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -311.00K$ -272.00K$ -326.00K$ -155.00K$ -78.00K
Operating Expenses
$ 41.76M$ 36.53M$ 50.47M$ 42.80M$ 23.21M
Depreciation and Amortization
$ 311.00K$ 272.00K$ 326.00K$ 155.00K$ 78.00K
EBITDA
$ -41.45M$ -35.08M$ -50.14M$ -42.65M$ -23.14M
Operating Income
$ -41.76M$ -36.53M$ -50.47M$ -42.80M$ -23.21M
Other Income/Expenses
$ 4.81M$ 1.17M$ -171.00K$ 322.00K$ 82.00K
Pretax Income
$ -36.95M$ -35.35M$ -50.64M$ -42.48M$ -23.13M
Net Income
$ -36.95M$ -34.18M$ -50.31M$ -42.33M$ -23.13M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.84$ -1.33$ -2.93$ -3.56$ -2.51
Diluted EPS
$ -0.84$ -1.33$ -2.93$ -3.56$ -2.51
Weighted Average Shares Outstanding
43.90M 25.76M 17.16M 11.88M 9.21M
Weighted Average Shares Outstanding (Diluted)
43.90M 25.76M 17.16M 11.88M 9.21M
Currency in USD

Larimar Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis